Post Graduate Diploma in Pharmaceutical Business Analytics (12 months)

Executive Diploma in Pharmaceutical Business Analytics (6 months)

Industry Certificate in Pharmaceutical Business Analytics (3-4 months)

www.igmpi.ac.in


About IGMPI


The Institute of Good Manufacturing Practices India, registered under SR Act XXI of 1860, Government of India, recognised by Ministry of Commerce & Industry, accredited Vocational Institution of Ministry of Education, Government of India and approved by Food Safety and Standards Authority of India (FSSAI) presents a unique, friendly and interactive platform to get rid of all your GMP compliance related issues. GMP- an essential element of industries like pharmaceutical, cosmetic, Ayurveda, biotech, homeopathic, medical device and food manufacturing and sustainability services - in itself is the most dynamic part which witnesses frequent changes in terms of new rules being added and old ones being renewed. Thus, keeping oneself updated with current GMPs is essential to remain aligned with evolving industry requirement and standards.

Our team comprises knowledgeable professionals from diverse sectors such as Pharma, Healthcare, Food & Nutraceutical industries, pooling together their expertise, know-how, and practical experiences to create this GMP guide. IGMPI is moving hand in hand with technology advances and has gained recognition as a stronger and better education and training platform provider for professionals and students in the areas of GMP, Quality Assurance and Control, Pharma, Food & Nutrition and Healthcare Regulatory Affairs, Clinical Research, Pharmaceutical IPR and Good Laboratory Practice and Product Management. Our board of governors and specialists have collated their acumen and are offering state-of-the-art courses which includes GMP training, Quality Assurance and Control, Pharma and healthcare Regulatory Affairs, Clinical Research, Pharmaceutical IPR, Environment Social Governance (ESG), and Good Laboratory Practice in form of formal classroom studies, online/interactive programmes, online seminars, as well as onsite training programmes along with the knowledge of worldwide affairs of the industry. In short, a round-the-clock service is provided for any information in these areas required by anybody from around the country and abroad. Based on high standards of quality, the training programmes in Pharma, Healthcare and Food GMP, Quality Assurance and Quality Control, Regulatory Affairs, IPR, Pharma Product Management, Public Health, Hospital Management, Clinical Research, Pharmacovigilance, Medical Writing, Medical Coding, Nanotechnology, Drug Design and Discovery, Food QA&QC, etc., areas have been approved by Quality Council of India, which is an autonomous body and an accreditation authority for education & vocational training providers under the Ministry of Commerce & Industry, Government of India. IGMPI is duly licensed and certified by Bureau of Indian Standards (BIS) under Bureau of Indian Standards (Conformity Assessment) Regulations 2018.

Accreditation and Awards

IGMPI is recognized by the Ministry of Commerce & Industry, Government of India and duly licensed and certified by Bureau of Indian Standards (BIS) under Bureau of Indian Standards (Conformity Assessment) Regulations 2018 (License number: ERO/EOMSM/L-8000027) for offering education and training programmes, services and processes in the areas of Pharmaceutical, Food, Nutrition, Healthcare, Environment Health & Safety (EHS), Environmental Social & Governance (ESG) and Marketing Communications.

Ministry of Commerce & Industry
Bureau of Indian Standards

Institute of Good Manufacturing Practices India (IGMPI) is registered as a non-profit society with its own Memorandum of Association and bye-laws under The Societies Registration Act, 1860, Government of India. IGMPI is an accredited Vocational Institution of Ministry of Education, Government of India.

The Post Graduate and Executive Diploma programmes of IGMPI in Good Manufacturing Practices, Regulatory Affairs, Intellectual Property Rights, Quality Assurance and Quality Control, Public Health, Nanotechnology, Hospital Management, Product Management, Sales and Marketing Management, Clinical Research, Medical Writing, Drug Discovery and Development, Pharmacovigilance, Medical Coding have been duly assessed and approved by Quality Council of India, Government of India based on fulfillment of QCI's following criteria:

  1. Programme Content
  2. Programme Design
  3. Programme Material
  4. Instructors
  5. Class size & Attendance
  6. Facilities
  7. Evaluation of Students
  8. Written Examination
  9. Certificate

IGMPI is also approved by Food Safety and Standards Authority of India (FSSAI) (FSSAI ID: TPINS18). IGMPI® is licensed by Department of Food Safety & Drug Administration under the Drugs and Cosmetics Act, 1940 and registered under Food Safety and Standards Act 2006.

IGMPI has been conferred with the prestigious "BUREAU OF INDIAN STANDARDS (BIS) AWARD OF HONOUR 2023". QUALITY COUNCIL OF INDIA (QCI) has also conferred IGMPI with D.L. SHAH NATIONAL QUALITY AWARD, Certificate of Merit & ASSOCHAM has conferred IGMPI with the Services Excellence Award based on excellence of its services to the students and training participants.

IGMPI's Membership with IPA

IGMPI is a Lifetime Institutional member of Indian Pharmaceutical Association (IPA).

IPA

Bureau of Indian Standards (BIS)

Bureau of Indian Standards (BIS) came into existence through an act of Parliament in 1987. BIS is the National Standard Body of India established under the BIS Act 2016 for the harmonious development of the activities of standardization, marking and quality certification of goods and for matters connected therewith or incidental thereto. The Bureau is a Body consisting of 25 members representing both Central and State governments, Members of Parliament, industry, scientific and research institutions, consumer organizations and professional bodies; with Union Minister of Consumer Affairs, Food and Public Distribution as its President and with Minister of State for Consumer Affairs, Food and Public Distribution as its Vice-President.

Quality Council of India (QCI)

Quality Council of India is set up by the Government of India to establish and operate national accreditation structure and promote quality through National Quality Campaign. QCI is registered as a non-profit society with its own Memorandum of Association. QCI is governed by a Council of 38 members and Chairman of QCI is appointed by the Prime Minister on recommendation of the industry to the government. The Department of Industrial Policy & Promotion, Ministry of Commerce & Industry, is the nodal ministry for QCI.

International Recognition

For providing its education and training services to overseas students, IGMPI is registered with the Directorate General of Foreign Trade, Government of India and our Export Import Code is AADCI7680Q.

IGMPI is an Institutional Member of the International Society for Quality in Health CarelSQua

Bureau of Indian Standards (BIS) is a member of International Organization for Standardization (ISO) and through the Indian National Committee (INC) which is a member of International Electrotechnical Commission (IEC). BIS is also a member of regional standards bodies like Pacific Area Standards Congress (PASC) and South Asian Regional Standards Organization (SARSO). India started taking part in IEC from 1911 and subsequently the then Indian Standards Institution (now BIS) took over the responsibility of Indian National Committee of IEC(INC-IEC) in 1949. Since then the INC-IEC is actively participating in the activities of the IEC both at the policy level and technical work and carrying out the responsibilities as member body of IEC Council. India is a member in Standards Management Board (SMB) of IEC since 2015.BIS has also signed Bilateral Cooperation Agreements (BCA)/Mutual Recognition Agreements (MRA) with the National Standards Bodies of several countries like Afghanistan, Bangladesh, Belarus, Egypt, European Union , Germany, Ghana, Greece, Indonesia, Iran, Japan, Jordon, Kenya, Kyrgyzstan, Mali, Mauritius, Nigeria, Russia, Saudi Arabia , Slovakia, Slovenia, Suriname, USA, UAE, Uzbekistan, Viet Nam, Bhutan, Brazil, Israel, Nepal, Pakistan and Sri Lanka.

National Accreditation Board for Certification Bodies (NABCB), Quality Council of India is a member of International Accreditation Forum (IAF) & Pacific Accreditation Cooperation (PAC) as well as signatory to its MLAs for Quality Management Systems, Environmental Management Systems and Product Certification. NABCB is also a Full Member of International Laboratory Accreditation Cooperation (ILAC) & Asia Pacific Laboratory Accreditation Cooperation (APLAC) as well as signatory to its MRAs for Inspection.


Post Graduate Diploma/Executive Diploma/Industry Certificate in Pharmaceutical Business Analytics


Pharmaceutical business analytics plays a critical role in the industry by leveraging data-driven insights to enhance decision-making, improve efficiency, and drive strategic initiatives. Pharmaceutical business analytics is integral to the industry as it harnesses data to drive informed decision-making and strategic advancements. It plays a crucial role across drug discovery, optimizing clinical trials, and enhancing market research for effective commercialization. By analyzing real-world data and regulatory compliance, it ensures safety and efficacy throughout a product's lifecycle. Analytics also supports sales and marketing effectiveness by optimizing promotional strategies and customer engagement. In supply chain management, it improves inventory optimization and supplier relationships, while in health economics, it evaluates cost-effectiveness and outcomes research. Ultimately, pharmaceutical business analytics empowers stakeholders with actionable insights, enabling them to navigate complexities, innovate efficiently, and deliver impactful healthcare solutions.

In essence, pharmaceutical business analytics transforms raw data into actionable insights that drive innovation, efficiency, compliance, and patient-centricity within the industry. It supports strategic decision-making across all facets of pharmaceutical operations, ultimately leading to improved healthcare outcomes and sustained business success.

This program will enable the participants to:

  • Optimize Drug Discovery and Development: Analytics helps pharmaceutical companies optimize their drug development processes. By analyzing clinical trial data, researchers can identify patterns, predict outcomes, and streamline trials, thereby reducing costs and time-to-market for new medications. This efficiency is crucial in addressing healthcare needs promptly.
  • Market Research and Commercialization: Analytics allows companies to understand market dynamics, patient demographics, and physician preferences. This insight enables targeted marketing strategies, better resource allocation, and the development of tailored therapies that meet specific patient needs. It also helps in identifying new market opportunities and optimizing pricing strategies.
  • Sales and Marketing Effectiveness: Promotion Optimization: Analytics evaluates the effectiveness of marketing campaigns, detailing physician engagement, promotional ROI, and sales impact. This guides resource allocation and improves campaign targeting. Customer Relationship Management: By integrating sales data with physician prescribing patterns and customer interactions, analytics enhances customer relationship management (CRM) strategies and fosters stronger relationships with healthcare providers.
  • Improve Operational Efficiency: Pharmaceutical business analytics helps in optimizing supply chain management, inventory control, and production processes. By analyzing sales forecasts, demand patterns, and distribution data, companies can minimize wastage, reduce stockouts, and improve overall operational efficiency.
  • Enhance Regulatory Compliance: Analytics aids in ensuring regulatory compliance by tracking and analyzing adherence to safety protocols, clinical trial regulations, and pharmacovigilance requirements. This capability helps companies mitigate risks, ensure patient safety, and maintain good standing with regulatory authorities.
  • Support Strategic Decision-Making: Analytics provides executives and decision-makers with actionable insights based on robust data analysis. This includes evaluating business performance metrics, assessing the success of marketing campaigns, identifying cost-saving opportunities, and making informed decisions about portfolio management and partnerships.
  • Predictive and Prescriptive Analytics: By using predictive analytics models, pharmaceutical companies can forecast future trends, anticipate market shifts, and identify potential risks. Prescriptive analytics goes a step further by recommending specific actions to optimize outcomes based on predictive insights. These capabilities empower companies to proactively address challenges and capitalize on opportunities.
  • Health Economics and Outcomes Research (HEOR): Analytics enables a more patient-centric approach to healthcare by analyzing real-world data (RWD) from electronic health records, wearables, and patient-reported outcomes. This data helps in understanding treatment effectiveness, patient adherence, and outcomes, leading to personalized medicine and improved patient care.
  • Competitive Advantage: In a competitive industry like pharmaceuticals, companies that effectively harness analytics gain a competitive edge. They can innovate faster, respond to market changes swiftly, and differentiate themselves through data-driven strategies that deliver superior outcomes for patients and stakeholders.

Programme Modules

Module 1: Introduction to Pharmaceutical Business Analytics

Module 2: Principles of Management

Module 3: Pharmaceutical Marketing Management, Pharmaceutical segmentation outlook

Module 4: Pharmaceutical Sales & Advertising Management

Module 5: Drug development processes

Module 6: Introduction to Big Data Analytics

Module 7: Data Management and Data Warehousing

Module 8: Data Analysis and Visualization

Module 9: Data Integration and Data Quality

Module 10: Implementation of Big Data Analytics in Pharmaceutical and Healthcare Industry

Module 11: Analytics Tools and Technologies (SAS, R, Python, SQL, Tableau, Power BI, SPARK, HADOOP)

Module 12: Artificial Intelligence and Machine Learning

Module 13: Regulatory and Compliance (FDA and EMA)

Module 14: Global Healthcare Data Protection (HITECH, PPACA, GDPR and HIPAA)

Module 15: Data Protection Regulations in India

Module 16: Health Economics and Outcomes Research (HEOR)

Module 17: Industry Based Case Studies

Eligibility

Any Graduation/ B.tech/ B.Sc. in Microbiology/ Life Sciences/ Botany/ Zoology/ Food Science/ Food Technology/ BE/ B.Pharma/ MBBS/ BDS/ BHMS/ BUMS/ BAMS or any other discipline. Diploma holders are eligible for our Executive Diploma, Industry Certificate, and Certificate Programmes.

Programme Duration

The duration to complete this programme is 1 year (Post Graduate Diploma), 6 months (Executive Diploma), 3-4 months (Industry Certificate).

Registration

The registration dates for this program run by the Institute are updated timely on the webpage. Effective online learning tools incorporated into the design of the webpage make the program lectures, online live classes and study material easily accessible. This gives a huge window of self-regulated and self-paced performance to the participants.

Programme Deliverables

A comprehensive study material for all the modules in hard copies ensuring the needs of the audience. The accompanying training material is appropriately aligned with the current Industry’s expectations.

  • Assignments for all the programme modules for continuous evaluation and guidance.
  • Interactive or online live sessions on all key areas of the programme giving all flexibility to the participants.
  • Online classes for all the modules will be conducted on the weekends. Moreover, a doubt clearing session will also be scheduled before the examination
  • All the efforts are made by IGMPI faculty members to make the entire programme modules easily understandable.
  • Assessment and evaluation for all the programme modules in order to enhance the levels of competencies and skills of the participants leading towards the objective of application in the job.
  • At the end of each programme modules, the trainers shall obtain feedback from the participants using specially designed questionnaires.
  • All learning and training delivery initiatives shall be conducted in English.

Examination and Certification

IGMPI follows a credit system based on all learning activities involved in studying for all PG Diploma, Executive Diploma and Certificate Programs. Each of your modules is equal to 4 credits. To successfully complete the program, you will have to earn all the credits assigned to your program.

All the participants are obliged to timely submit completed assessment assignments (during the program, usually after every module) and appear for an online exam at the end of the program. After successful completion, the participants will receive a certificate of Post Graduate Diploma/Executive Diploma/Industry Certificate in Pharmaceutical Business Analytics, IGMPI. For all the above-mentioned modules, Online Classes (Online mode) or face-to-face classes (Regular mode), elaborate program material, self-assessment assignments would be provided by the Institute. Details get updated on the webpage as well.

Placement Assistance & Corporate Relations

The Institute has partnered with many organizations for providing with placement assistance to its participants. Besides, it has a robust placement cell comprised of senior level Human Resources professionals and Talent Acquisition experts which maintains close links with business and industry. This cell is continuously engaged in promoting the employability of our participants and encouraging the concerned Human Resources department and Hiring Managers to recruit/hire our participants for their vacant positions. The efforts of our placement cell also include helping with professional resume writing & interview skills.

In recent months the Institute has witnessed more and more participation from professionals working with global pharmaceutical, healthcare like Johnson & Johnson, Roche, Novartis, Merck & Co., AbbVie, GlaxoSmithKline, Pfizer, Sanofi, Bayer, Eli Lilly & Co., Novo Nordisk, Astra Zeneca, Teva Pharmaceutical Industries, Dr. Reddy’s Laboratories, Lupin Limited, Torrent Pharmaceutical Ltd., Emcure Pharmaceuticals, Sun Pharmaceutical Limited, Mankind Pharma, Ajanta Pharma, IPCA Laboratories etc., Gland Pharma, Baxter, Jubilant Generics Limited, Sun Pharmaceutical Industry, Merck Group, Johnson & Johnson, Cipla Limited, etc. Placement in IT companies like SAP, MedismoPharma CRM, Logic Pharma, MARG ERP 9, Tata Consultancy Services, and Wipro. More and more participation from professionals working with global healthcare like Cognizant, Accenture, Deloitte, Infosys, The Emmes Company, MPREX Healthcare, IQVIA, Syneos Health, Parexel, PRA Health Sciences, ICON, Labcorp, Tata Consultancy Services, Accenture, Cognizant Technology Solutions, Indegene, iMedglobal, Lotus Labs, Aris Global, ClinicVA Healthcare Solutions, Accenture, Apollo Hospital, Genpact, MPREX Healthcare, etc. The IGMPI’s Corporate Resource Division actively recommends our students and training participants for various job requirements and specialized roles to Human Resource, Talent Acquisition as well as the heads of various departments in Pharmaceutical industries on regular basis.

Future career prospects

The future career prospects for Pharmaceutical Business Analytics are robust and diverse, driven by the industry's increasing reliance on data-driven decision-making and technological advancements. As pharmaceutical companies continue to embrace digital transformation, there is a growing demand for professionals skilled in data science, artificial intelligence (AI), and machine learning. Careers in this field will focus on leveraging these technologies to optimize drug discovery, personalize medicine through genomic insights, and streamline clinical trials for efficiency and cost-effectiveness. Moreover, the emphasis on real-world evidence (RWE) and health economics outcomes research (HEOR) is expanding opportunities in analyzing patient data to demonstrate treatment efficacy and value to stakeholders. Regulatory compliance and pharmacovigilance roles will also see growth, ensuring adherence to stringent regulatory standards through advanced analytics and data management practices. Overall, careers in Pharmaceutical Business Analytics will continue to evolve, offering opportunities in innovative research, strategic decision-making, and operational excellence within the global healthcare landscape.


Advisory Board and team


Our Advisory Board Members : https://igmpi.ac.in/advisoryboard.html


Institute of Good Manufacturing Practices India

C-6, Qutab Institutional Area, Near Old JNU Campus, New Delhi-110016
18001031071 (Toll Free), Phone: +91 11 26512850